Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sharon Abrahams

Showing results (91-100 of 118) with videos related to

Pageof 12
Sort By:
Brain Communications|June 8, 2023
Cognitive and neuropsychiatric endophenotypes in amyotrophic lateral sclerosisEmmet Costello, Marie Ryan, Bronagh Donohoe, et al.
Journal of Clinical Neurology (Seoul, Korea)|November 6, 2024
Erratum: Development and Validation of the Korean Version of the Edinburgh Cognitive and Behavioral Amyotrophic Lateral Sclerosis Screen (ECAS-K)Jeeun Lee, Ahwon Kim, Seok-Jin Choi, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|April 29, 2025
Impact of apathy over the course of disease in amyotrophic lateral sclerosisRatko Radakovic, Debbie Gray, Ana Paula Trucco, et al.
Journal of Clinical Neurology (Seoul, Korea)|July 25, 2023
Development and Validation of the Korean Version of the Edinburgh Cognitive and Behavioral Amyotrophic Lateral Sclerosis Screen (ECAS-K)Jeeun Lee, Ahwon Kim, Seok-Jin Choi, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|March 31, 2016
Age and education-matched cut-off scores for the revised German/Swiss-German version of ECASMarkus Loose, Christian Burkhardt, Helena Aho-Özhan, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|December 9, 2025
Utility of patient subgrouping in ALS clinical trials: a World Federation of Neurology white paperJeffrey Rosenfeld, Sharon Abrahams, Caroline McHutchinson, et al.
The Lancet. Neurology|April 23, 2011
Towards a neuroimaging biomarker for amyotrophic lateral sclerosisMartin R Turner, Julian Grosskreutz, Jan Kassubek, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|January 6, 2026
Prioritizing neuropsychological research and care in Amyotrophic Lateral Sclerosis (ALS): building an international neuropsychological framework for ALSJoke De Vocht, Emmet Costello, Caroline McHutchison, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|December 8, 2017
Measuring reliable change in cognition using the Edinburgh Cognitive and Behavioural ALS Screen (ECAS)Christopher Crockford, Judith Newton, Katie Lonergan, et al.
The Journal of Pathology|September 7, 2022
Random forest modelling demonstrates microglial and protein misfolding features to be key phenotypic markers in C9orf72-ALSOlivia M Rifai, James Longden, Judi O'Shaughnessy, et al.
Pageof 12

Showing results (91-100 of 118) with videos related to

Sort By:
Pageof 12
Brain Communications|June 8, 2023
Cognitive and neuropsychiatric endophenotypes in amyotrophic lateral sclerosisEmmet Costello, Marie Ryan, Bronagh Donohoe, et al.
Journal of Clinical Neurology (Seoul, Korea)|November 6, 2024
Erratum: Development and Validation of the Korean Version of the Edinburgh Cognitive and Behavioral Amyotrophic Lateral Sclerosis Screen (ECAS-K)Jeeun Lee, Ahwon Kim, Seok-Jin Choi, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|April 29, 2025
Impact of apathy over the course of disease in amyotrophic lateral sclerosisRatko Radakovic, Debbie Gray, Ana Paula Trucco, et al.
Journal of Clinical Neurology (Seoul, Korea)|July 25, 2023
Development and Validation of the Korean Version of the Edinburgh Cognitive and Behavioral Amyotrophic Lateral Sclerosis Screen (ECAS-K)Jeeun Lee, Ahwon Kim, Seok-Jin Choi, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|March 31, 2016
Age and education-matched cut-off scores for the revised German/Swiss-German version of ECASMarkus Loose, Christian Burkhardt, Helena Aho-Özhan, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|December 9, 2025
Utility of patient subgrouping in ALS clinical trials: a World Federation of Neurology white paperJeffrey Rosenfeld, Sharon Abrahams, Caroline McHutchinson, et al.
The Lancet. Neurology|April 23, 2011
Towards a neuroimaging biomarker for amyotrophic lateral sclerosisMartin R Turner, Julian Grosskreutz, Jan Kassubek, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|January 6, 2026
Prioritizing neuropsychological research and care in Amyotrophic Lateral Sclerosis (ALS): building an international neuropsychological framework for ALSJoke De Vocht, Emmet Costello, Caroline McHutchison, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|December 8, 2017
Measuring reliable change in cognition using the Edinburgh Cognitive and Behavioural ALS Screen (ECAS)Christopher Crockford, Judith Newton, Katie Lonergan, et al.
The Journal of Pathology|September 7, 2022
Random forest modelling demonstrates microglial and protein misfolding features to be key phenotypic markers in C9orf72-ALSOlivia M Rifai, James Longden, Judi O'Shaughnessy, et al.
Pageof 12